Press release
FMI Releases New Report on the Global Hepatocellular Carcinoma HCC Treatment Market
Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated to witness rise in incidence rate during the forecast period. HCC is currently expected to be the third leading cause of death worldwide. In the past, HCC generally occurred at an advanced stage of decompensated liver disease or cirrhosis. The technological advancements and the routine liver function tests are now resulting in the early detection of hepatocellular carcinoma. The increase in incidences of hepatocellular carcinoma associated with hepatitis C virus are expected to grow the hepatocellular carcinoma treatment market during the forecast period.
Hepatocellular Carcinoma(HCC) Treatment Market: Drivers and Restraints
The incidence rate of hepatic cancer such as intrahepatic bile duct cancer in U.S. was approximately 39,230 during 2015. The risk factors associated with hepatocellular carcinoma are Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection, alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, and chronic liver injury. The advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to keep up the growth of global hepatocellular carcinoma treatment market. However, side effects associated with the chemotherapy, high cost of treatment are some of the major restraints limiting the growth of global hepatocellular carcinoma treatment market.
Hepatocellular Carcinoma(HCC) Treatment Market: Segmentation
The global hepatocellular carcinoma (HCC) treatment market has been segmented on the basis of application, end use and geography.
Based on application, the global hepatocellular carcinoma (HCC) treatment market is segmented into:
Brachytherapy
Chemotherapy
Local Ablation Therapy
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1370
Based on end user type, the global hepatocellular carcinoma (HCC) treatment market is segmented into:
Hospitals
Clinics
Cancer rehabilitation centers
Hepatocellular Carcinoma(HCC) Treatment Market: Overview
Inventions in technologies for cancer treatment procedures are expected to launch into the market in the forecast period. Moreover, the increasing investment of pharmaceutical companies in the research and development of anticancer drugs would contribute to the growth of hepatocellular carcinoma treatment market. Monoclonal antibodies and other immunological treatments are generally known for their lesser side effects and better efficacy.
Hepatocellular Carcinoma(HCC) Treatment Market: Regional Overview
Geographically, the global Hepatocellular Carcinoma (HCC) treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa.Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infections are found to be the most significant cause of hepatocellular carcinoma. Chronic HBV infection is the principal cause of hepatocellular carcinoma in Asia and Africa. HCV infection is the principal cause of hepatocellular carcinoma in North America, Europe, and Japan. The global hepatocellular carcinoma treatment market is expected to grow in future due to increasing investment by multinational companies in the cancer research.
Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1370
Hepatocellular Carcinoma(HCC) Treatment Market: Key Players
Bayer AG is one of the leading provider of hepatocellular carcinoma (HCC) treatment drugs. Some of the key players in hepatocellular carcinoma treatment market are Novartis Pharmaceuticals, Merck & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Johnson & Johnson Pvt. Ltd., Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. These companies focuses on the priority areas of the antiviral and oncology in order to address unmet medical needs
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FMI Releases New Report on the Global Hepatocellular Carcinoma HCC Treatment Market here
News-ID: 332763 • Views: …
More Releases from FMI Research
Model Based Manufacturing Technologies Market Key Growth Factors and Industry An …
There is a tectonic shift in the global manufacturing vertical, which is rapidly transforming the existing production lines as well as adding more dynamism to them. The trend of data exchange and automation in manufacturing technologies has led to the rise of Industry 4.0, more popularly known as smart factories. Modern day factories follow certain models that allow more efficient, systematic and cost-effective manufacturing. In order to stay competitive, manufacturers…
Wearable Fitness Trackers Market Trends and Segments 2017-2025
Global wearable fitness trackers market is expected to witness significant growth during the forecast period. This growth is attributed to increasing number of corporate players in the market. The market is also increasing due to adoption of new technologies such as CGM (Constant Glucose Monitoring), which is gaining the customer’s interest in wearable fitness trackers. “Wearable Fitness Trackers Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),” is the newly published report by Future…
Public Cloud Application Services Market: 2016 Global Manufacturers Analysis wit …
The public cloud application infrastructure service market is gaining huge popularity throughout the world. This is evident due to the recent shift in enterprise business models that have now adopted cloud based services to revolutionize the concept of flexibility of infrastructure. Cloud computing is making rapid inroads and majority of companies are adopting the cloud model. This is because of the various advantages that the cloud model brings such as…
Healthcare Revenue Cycle Management Software Market Key Growth Factors and Indus …
The adoption of revenue cycle management software and services in healthcare settings is driven by the need to increase net patient revenue, improve payment collection & billing efficiency, and recognise cash flow opportunities. From hospitals to independent physician clinics, the stress of enhancing the quality of patient care is increasing in parallel to the declining reimbursements and increasing risk-margin burdens. Since maximising the revenue cycle efficiency is a key focus…
More Releases for HCC
HCC Hajec Concrete Coatings Provides Excellent and Long-Lasting Services
Image: https://www.getnews.info/wp-content/uploads/2024/07/1721836514.jpeg
HCC Hajec Concrete Coatings is well known for offering long-lasting concrete coatings services. The company specializes in exceptional results that last long in residential, commercial, and industrial settings. Because they care about quality and ensure their customers are happy, HCC Hajec Concrete Coatings has become a well-known brand.
Littleton, CO - The skilled workers at HCC Hajec Concrete Coatings use cutting-edge methods and premium supplies to ensure the coatings work…
Hepatocellular Carcinoma (HCC) Treatment: Massive R&D Investments and Rising Cas …
A recent research report by MarkNtel Advisors has revealed that the Global Hepatocellular Carcinoma (HCC) Market is set to record around 10.20% CAGR during 2022-27. The rising patient pool of HCC due to the rapidly increasing elderly population levels worldwide, coupled with growing lifestyle disorders, are the prime aspects projected to drive the market in the forecast years. In addition, substantial R&D investments in discovering more effective HCC therapeutics, backed…
Hepatocellular Carcinoma HCC Treatment Market Segments and Supply Demand 2016-20 …
Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated…
Hepatocellular Carcinoma HCC Treatment Market Growth and Forecast 2016-2026
Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated…
Hepatocellular Carcinoma HCC Treatment Market size and forecast, 2016-2026
Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated…
Hepatocellular Carcinoma HCC Treatment Market To Increase at Steady Growth Rate
Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated…
